biOasis Technologies Inc
XTSX:BTI

Watchlist Manager
biOasis Technologies Inc Logo
biOasis Technologies Inc
XTSX:BTI
Watchlist
Price: 0.005 CAD Market Closed
Market Cap: CA$10k

Operating Margin

-1 141.1%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 141.1%
=
Operating Income
CA$-3.1m
/
Revenue
CA$269.4k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 141.1%
=
Operating Income
CA$-3.1m
/
Revenue
CA$269.4k

Peer Comparison

Country Company Market Cap Operating
Margin
CA
biOasis Technologies Inc
XTSX:BTI
10k CAD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
387.5B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.5B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
168.8B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.3B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.2B USD
Loading...

Market Distribution

Lower than 90% of companies in Canada
Percentile
10th
Based on 4 855 companies
10th percentile
-1 141.1%
Low
-4 710 029.9% — -65.8%
Typical Range
-65.8% — 11%
High
11% — 71 100%
Distribution Statistics
Canada
Min -4 710 029.9%
30th Percentile -65.8%
Median -2.4%
70th Percentile 11%
Max 71 100%

biOasis Technologies Inc
Glance View

Market Cap
10k CAD
Industry
Biotechnology

biOasis Technologies, Inc. operates as a biopharmaceutical company. The company is headquartered in Richmond British Columbia, British Columbia. The company went IPO on 2007-07-24. The firm is engaged in the development of the xB3 platform, a technology for the delivery of therapeutics across the blood brain barrier (BBB) and the treatment of central nervous system (CNS) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. xB3 is based on a human transport protein found circulating at low levels in the blood. The xB3 platform has an efficacy in its ability to shuttle molecules across the blood-brain barrier and reach its targets within the brain through a process called receptor-mediated transcytosis. The in-house development programs at Bioasis are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

BTI Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-1 141.1%
=
Operating Income
CA$-3.1m
/
Revenue
CA$269.4k
How has Operating Margin changed over time?

Over the last 3 years, biOasis Technologies Inc’s Operating Margin has decreased from -732.1% to -1 141.1%. During this period, it reached a low of -9 532.9% on Feb 28, 2022 and a high of 9.3% on Feb 28, 2021.

Back to Top